Magazine

The leading source for ASAM society and addiction medicine news.

ASAM's Legislative Day Wrap-Up

by Beth Haynes | Oct 28, 2013

On October 23rd, ASAM hosted Legislative Day at Capitol Hill. Legislative Day is an opportunity for ASAM members to meet with their Congressional leaders to discuss key ASAM issues, share concerns and impart their expertise on issues related to drug and addiction treatment policies. The day began with an advocacy training and breakfast orientation in Washington, D.C. Congressman Tim Ryan (Ohio) spoke at the morning’s event, provided tips and answered members’ questions.

Approximately 40 ASAM members met with members of Congress and their staff to discuss key policy issues, including the implementation of the parity law and combating and treating prescription drug abuse. A total of about 90 meetings were scheduled.

Congressional leaders were asked to sign a letter requesting Agencies release final or sub-regulatory guidance on disclosure of medical necessity criteria, scope of service including parity in addiction medications and rules for use of non-quantitative treatment limits.

Features

Education & Training

ASAM's Legislative Day Wrap-Up

by Beth Haynes | Oct 28, 2013

On October 23rd, ASAM hosted Legislative Day at Capitol Hill. Legislative Day is an opportunity for ASAM members to meet with their Congressional leaders to discuss key ASAM issues, share concerns and impart their expertise on issues related to drug and addiction treatment policies. The day began with an advocacy training and breakfast orientation in Washington, D.C. Congressman Tim Ryan (Ohio) spoke at the morning’s event, provided tips and answered members’ questions.

Approximately 40 ASAM members met with members of Congress and their staff to discuss key policy issues, including the implementation of the parity law and combating and treating prescription drug abuse. A total of about 90 meetings were scheduled.

Congressional leaders were asked to sign a letter requesting Agencies release final or sub-regulatory guidance on disclosure of medical necessity criteria, scope of service including parity in addiction medications and rules for use of non-quantitative treatment limits.

Government Affairs

ASAM's Legislative Day Wrap-Up

by Beth Haynes | Oct 28, 2013

On October 23rd, ASAM hosted Legislative Day at Capitol Hill. Legislative Day is an opportunity for ASAM members to meet with their Congressional leaders to discuss key ASAM issues, share concerns and impart their expertise on issues related to drug and addiction treatment policies. The day began with an advocacy training and breakfast orientation in Washington, D.C. Congressman Tim Ryan (Ohio) spoke at the morning’s event, provided tips and answered members’ questions.

Approximately 40 ASAM members met with members of Congress and their staff to discuss key policy issues, including the implementation of the parity law and combating and treating prescription drug abuse. A total of about 90 meetings were scheduled.

Congressional leaders were asked to sign a letter requesting Agencies release final or sub-regulatory guidance on disclosure of medical necessity criteria, scope of service including parity in addiction medications and rules for use of non-quantitative treatment limits.

OP-ED

ASAM's Legislative Day Wrap-Up

by Beth Haynes | Oct 28, 2013

On October 23rd, ASAM hosted Legislative Day at Capitol Hill. Legislative Day is an opportunity for ASAM members to meet with their Congressional leaders to discuss key ASAM issues, share concerns and impart their expertise on issues related to drug and addiction treatment policies. The day began with an advocacy training and breakfast orientation in Washington, D.C. Congressman Tim Ryan (Ohio) spoke at the morning’s event, provided tips and answered members’ questions.

Approximately 40 ASAM members met with members of Congress and their staff to discuss key policy issues, including the implementation of the parity law and combating and treating prescription drug abuse. A total of about 90 meetings were scheduled.

Congressional leaders were asked to sign a letter requesting Agencies release final or sub-regulatory guidance on disclosure of medical necessity criteria, scope of service including parity in addiction medications and rules for use of non-quantitative treatment limits.

Your ASAM

Photo of Alex Krawczyk-KeefeThe Importance of Donating: One Family’s Story

A donation to honor a son and help those facing the devastating disease of addiction.

ASAM Speaks on FDA Boxed Warnings

ASAM testified on the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine

Brain Stimulation as a Potential Treatment for Addiction

Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.

PCSS Graphic

Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/ AA, NA/ therapist) are typically required as part of addiction treatment.